Soru

Zorluk: OrtaDiagnostic Workup and Test Sequencing

During a new patient evaluation, a 34-year-old female is noted to have a blood pressure of 158/96158/96 mm Hg. She returns to the clinic two weeks later for a follow-up, and her blood pressure is 154/94154/94 mm Hg. The patient reports feeling entirely well, with no headaches, palpitations, or muscle weakness. She has no known medical conditions and takes no medications or over-the-counter supplements. She does not use tobacco or illicit substances. Her body mass index is 2323 kg/m 2^2. Physical examination reveals normal pulses in all extremities and no abdominal bruits. A comprehensive metabolic panel is obtained to assess baseline organ function, demonstrating a serum sodium of 143143 mEq/L, serum potassium of 3.13.1 mEq/L, serum chloride of 103103 mEq/L, serum bicarbonate of 2929 mEq/L, and serum creatinine of 0.80.8 mg/dL. Which of the following is the most appropriate next step in the diagnostic workup for this patient?

  1. Measurement of plasma aldosterone concentration and plasma renin activityCevap
  2. B
    Computed tomography of the adrenal glands
  3. C
    Intravenous saline infusion test
  4. D
    Renal artery duplex ultrasonography
  5. E
    Initiation of chlorthalidone therapy

Cevap

Measurement of plasma aldosterone concentration and plasma renin activity is the appropriate next step.
The correct answer proposes measuring the plasma aldosterone concentration and plasma renin activity. This patient's presentation of hypertension paired with unexplained, spontaneous hypokalemia and mild metabolic alkalosis is the classic biochemical signature of primary hyperaldosteronism. The absolute first step in the diagnostic sequence for this condition is obtaining a PAC/PRA ratio. In primary hyperaldosteronism, autonomous aldosterone production will result in an elevated PAC and a suppressed PRA, yielding a high ratio.

Adım Adım Çözüm

1
Analyze the patient's clinical and laboratory presentation.
The patient is a young female with newly diagnosed, sustained hypertension accompanied by spontaneous hypokalemia (3.13.1 mEq/L) and metabolic alkalosis (bicarbonate 2929 mEq/L).
Identifying these key features helps narrow the differential diagnosis for secondary hypertension.
2
Formulate a primary suspected diagnosis.
The triad of hypertension, spontaneous hypokalemia, and metabolic alkalosis in an otherwise healthy patient is highly suspicious for primary hyperaldosteronism (Conn syndrome).
Aldosterone promotes sodium reabsorption (driving hypertension) while increasing potassium and hydrogen ion excretion in the distal tubules (causing hypokalemia and metabolic alkalosis).
3
Determine the correct diagnostic testing sequence for the suspected condition.
The initial screening test for primary hyperaldosteronism is the measurement of plasma aldosterone concentration (PAC) and plasma renin activity (PRA) to calculate the PAC/PRA ratio.
Proper test sequencing requires highly sensitive, non-invasive biochemical screening prior to confirmatory suppression testing or advanced anatomical imaging.

Anahtar Kavram

The initial diagnostic step for suspected primary hyperaldosteronism is biochemical screening with a plasma aldosterone concentration to plasma renin activity ratio, which must precede any confirmatory testing or anatomical imaging.
Bu soruyu puanla